Aegis Capital Comments on Amarin (AMRN) Following Q2 Results, Commercialization Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Broadcom rises 3% on OpenAI custom "Jalapeño" chip reveal
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Amarin (AMRN): Goldman Remains Neutral as Investors Await FDA Response on ANCHOR Appeal
August 8, 2014 1:05 PM EDTGoldman Sachs maintained a Neutral rating on Amarin Corporation (NASDAQ: AMRN) with a price target of $1.90. Comments follow Q2 results. Analyst Gary Nachman said he was awaiting FDA response on its ANCHOR appeal.
"The Vascepa co-promote with Kowa began in mid-May and we have started to see a positive impact on Rxs, but it is... More
Amarin Corp plc (AMRN) Tops Q2 EPS by 1c
August 7, 2014 4:24 PM EDTAmarin Corp plc (NASDAQ: AMRN) reported Q2 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.86 million.
Amarin reported cash and cash equivalents of $150.5 million at June 30, 2014, representing a net decrease of $13.8 million from reported cash and cash equivalents of $164.3 million as of March 31, 2014... More
Amarin Corp plc (AMRN) Files $300M Mixed Securities Shelf
August 7, 2014 4:22 PM EDTAmarin Corp plc (NASDAQ: AMRN) filed a $300 million mixed securities shelf on form S-3.
... More